RecruitingNot ApplicableNCT05876923

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

The Effects of Acute and Chronic Exercise on the Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients


Sponsor

Mayo Clinic

Enrollment

70 participants

Start Date

Jun 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This clinical trial studies the effect of short-term (acute) and long-term (chronic) exercise on immune characteristics and function (phenotype) of patients with indolent non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring hospitalization and an increased risk of secondary non-blood-based (hematologic) cancers. Increasing CLL patients overall physical fitness levels, through exercise during the observation stage, may provide a realistic approach means to increase survival, decrease treatment-related side effects, and improve immune function. Information learned from this study may help researchers determine whether a particular exercise regimen can be used to strengthen the immune system of indolent NHL and CLL patients, delay time to disease progression, assess the need for treatment, and assess infection rates.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study looks at how exercise affects the immune system in people with slow-growing types of blood cancer, specifically indolent non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukemia (CLL). The goal is to understand if regular exercise can improve immune function in these patients. **You may be eligible if...** - You speak English and are between 18 and 80 years old - You have a confirmed diagnosis of indolent NHL or CLL/SLL - If currently on treatment, you have at least 8 weeks of treatment remaining - If post-treatment, you finished treatment at least 6 months ago with no more planned - If pre-treatment, you have no treatments scheduled during the 12-week study period **You may NOT be eligible if (healthy volunteers for Aim 1)...** - You have heart disease, COPD, asthma, or a physical limitation that prevents exercise - You are a current or former smoker **You may NOT be eligible if (lymphoma patients)...** - You have uncontrolled high blood pressure or heart problems - Your oncologist has not approved your participation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREBiospecimen Collection

Undergo collection of blood

OTHERCardiopulmonary Exercise Testing

Undergo CPET

PROCEDUREDual X-ray Absorptiometry

Undergo DEXA scan

OTHERElectronic Health Record Review

Ancillary studies

OTHERExercise Intervention

Undergo aerobic based training program

PROCEDUREPhysical Examination

Undergo measurement of height/weight and vital signs

OTHERQuestionnaire Administration

Ancillary studies

PROCEDURESpirometry

Undergo spirometry

OTHERPhysical Performance Testing

Undergo muscular strength and functional endurance measurements

OTHERBest Practice

Receive usual care


Locations(2)

Mayo Clinic in Arizona

Scottsdale, Arizona, United States

Mayo Clinic in Rochester

Rochester, Minnesota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05876923


Related Trials